Not provided
Not provided
Not provided
Not provided
Due to limited staff resources, we were unable to start enrolling participants.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to determine whether a simple text message reminder sent to the parent of an child/adolescent with Type 1 Diabetes(or parent and adolescent) is effective in helping the individual(or parent) become more compliant with self-managing the Type 1 Diabetes (T1D). There will be 5 arms: text message sent to parents of children age 8-12 years old with T1D, text messages sent to parents of adolescents ,age 13-18 years old, with T1D,text messages sent to parents of adolescents with T1D as well as the adolescent with T1D,no text message sent to parents of children age 8-12 years, and no text message sent to adolescents or parents of adolescents age 13-18 years old.
Managing Type 1 Diabetes requires daily checks of blood glucose and medication adjustments. Children and adolescents are known to have more difficulty with this than adults. Parents/legal guardians also face the task of helping with this self-management. A weekly text message regarding Type 1 Diabetes, sent to the parent or the parent and adolescent, may help to remind and motivate an individual to perform the daily tasks needed to manage their Type 1 Diabetes.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 8-12 years old, parent receiving text | Experimental | text message to parent only |
|
| 13-18 years old, parent receiving text | Active Comparator | text message to parent only |
|
| 13-18 years, both receiving text | Active Comparator | Text message to parent and adolescent |
|
| No text | No Intervention | No text will be sent |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| text message to parent only | Other | A weekly text message of an educational or motivational nature and related to Type 1 Diabetes will be sent for a duration of one year |
|
| Measure | Description | Time Frame |
|---|---|---|
| glycemic control assessed by HbA1C level. | review of lab value | up to one year after randomization occurs |
| Measure | Description | Time Frame |
|---|---|---|
| number of episodes of Diabetic Ketoacidosis (DKA) | chart review of self reported episodes of Diabetic Ketoacidosis and chart review of hospitalizations related to DKA | up to one year after randomization occurs |
| number of episodes of severe hypoglycemia |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gwendolyn S Pierce, MSN | University of Louisville | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of Louisville | Louisville | Kentucky | 40202 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D003922 | Diabetes Mellitus, Type 1 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| text message to parent and adolescent | Other | A weekly text message of an educational or motivational nature and related to Type 1 Diabetes will be sent for a duration of one year |
|
chart review of reported episodes of severe hypoglycemia and chart review of hospitalizations related to hypoglycemia |
| up to one year after randomization occurs |
| number of patient contacts to the diabetes educator | chart review of educator documentation of communication with subject | up to one year after randomization occurs |
| number of hospitalizations related to T1D | chart review of hospitalizations related to T1D | up to one year after randomization occurs |
| D004700 | Endocrine System Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |